Invivyd Inc. – Filings and Transcripts

NASDAQ: IVVD
Share price (11/5/26): $0.58
Market cap (11/5/26): $172 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration – amended

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Ownership Filter

Lee Timothy Edward

News Filter

Announces Positive Topline Results From LIBERTY Phase 3 Study Demonstrating VYD2311 Safety and Tolerability Superior to mRNA-based COVID-19 Vaccine; Announces Regulatory Submission Plans for VYD2311

Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 Studies DECLARATION and LIBERTY

Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps With the U.S. FDA

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission

Notice of effectiveness